Amgen Anemia Drug Tying Case Hangs By A Thread

Law360, New York (August 18, 2008, 12:00 AM EDT) -- A large portion of a purported antitrust class action against pharmaceutical giant Amgen Inc. has been booted out of court, following a federal judge's partial grant of the company's motion to dismiss charges by a welfare fund accusing it of illegally tying the sales of popular oncology treatments.

On Tuesday, Judge Stanley R. Chesler of the U.S. District Court for the District of New Jersey dismissed the Sheet Metal Workers National Health Fund's federal antitrust claims stemming from Amgen's practice of giving substantial rebates to oncology...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.